» Articles » PMID: 19478875

The Heart is an Early Target of Anthrax Lethal Toxin in Mice: a Protective Role for Neuronal Nitric Oxide Synthase (nNOS)

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2009 May 30
PMID 19478875
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Anthrax lethal toxin (LT) induces vascular insufficiency in experimental animals through unknown mechanisms. In this study, we show that neuronal nitric oxide synthase (nNOS) deficiency in mice causes strikingly increased sensitivity to LT, while deficiencies in the two other NOS enzymes (iNOS and eNOS) have no effect on LT-mediated mortality. The increased sensitivity of nNOS-/- mice was independent of macrophage sensitivity to toxin, or cytokine responses, and could be replicated in nNOS-sufficient wild-type (WT) mice through pharmacological inhibition of the enzyme with 7-nitroindazole. Histopathological analyses showed that LT induced architectural changes in heart morphology of nNOS-/- mice, with rapid appearance of novel inter-fiber spaces but no associated apoptosis of cardiomyocytes. LT-treated WT mice had no histopathology observed at the light microscopy level. Electron microscopic analyses of LT-treated mice, however, revealed striking pathological changes in the hearts of both nNOS-/- and WT mice, varying only in severity and timing. Endothelial/capillary necrosis and degeneration, inter-myocyte edema, myofilament and mitochondrial degeneration, and altered sarcoplasmic reticulum cisternae were observed in both LT-treated WT and nNOS-/- mice. Furthermore, multiple biomarkers of cardiac injury (myoglobin, cardiac troponin-I, and heart fatty acid binding protein) were elevated in LT-treated mice very rapidly (by 6 h after LT injection) and reached concentrations rarely reported in mice. Cardiac protective nitrite therapy and allopurinol therapy did not have beneficial effects in LT-treated mice. Surprisingly, the potent nitric oxide scavenger, carboxy-PTIO, showed some protective effect against LT. Echocardiography on LT-treated mice indicated an average reduction in ejection fraction following LT treatment in both nNOS-/- and WT mice, indicative of decreased contractile function in the heart. We report the heart as an early target of LT in mice and discuss a protective role for nNOS against LT-mediated cardiac damage.

Citing Articles

The effect of Ethanolic extract of Indonesian propolis on endothelial dysfunction and Multi Organ dysfunction syndrome in anthrax animal model.

Redhono D, Purwanto B, Wasita B, Indarto D, Setya Adji R, Kusumawardani A Saudi J Biol Sci. 2022; 29(2):1118-1124.

PMID: 35197781 PMC: 8847911. DOI: 10.1016/j.sjbs.2021.09.054.


The Group: Species with Pathogenic Potential.

Ehling-Schulz M, Lereclus D, Koehler T Microbiol Spectr. 2019; 7(3).

PMID: 31111815 PMC: 6530592. DOI: 10.1128/microbiolspec.GPP3-0032-2018.


Nitric oxide production contributes to Bacillus anthracis edema toxin-associated arterial hypotension and lethality: ex vivo and in vivo studies in the rat.

Li Y, Cui X, Xu W, Ohanjanian L, Sampath-Kumar H, Suffredini D Am J Physiol Heart Circ Physiol. 2016; 311(3):H781-93.

PMID: 27448553 PMC: 5142181. DOI: 10.1152/ajpheart.00163.2016.


Solid tumor therapy by selectively targeting stromal endothelial cells.

Liu S, Liu J, Ma Q, Cao L, Fattah R, Yu Z Proc Natl Acad Sci U S A. 2016; 113(28):E4079-87.

PMID: 27357689 PMC: 4948345. DOI: 10.1073/pnas.1600982113.


Does Bacillus anthracis Lethal Toxin Directly Depress Myocardial Function? A Review of Clinical Cases and Preclinical Studies.

Suffredini D, Sampath-Kumar H, Li Y, Ohanjanian L, Remy K, Cui X Toxins (Basel). 2015; 7(12):5417-34.

PMID: 26703730 PMC: 4690141. DOI: 10.3390/toxins7124891.


References
1.
Tsutsui M . Neuronal nitric oxide synthase as a novel anti-atherogenic factor. J Atheroscler Thromb. 2004; 11(2):41-8. DOI: 10.5551/jat.11.41. View

2.
OBrien P . Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker. Expert Rev Mol Diagn. 2006; 6(5):685-702. DOI: 10.1586/14737159.6.5.685. View

3.
Seddon M, Chowienczyk P, Brett S, Casadei B, Shah A . Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo. Circulation. 2008; 117(15):1991-6. DOI: 10.1161/CIRCULATIONAHA.107.744540. View

4.
Duesbery N, Webb C, Leppla S, Gordon V, Klimpel K, Copeland T . Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science. 1998; 280(5364):734-7. DOI: 10.1126/science.280.5364.734. View

5.
Loyer X, Samuel J, Heymes C . Cardiac myocyte neuronal nitric oxide synthase. New therapeutic target in heart failure?. Arch Mal Coeur Vaiss. 2006; 98(12):1244-8. View